http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021076598-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_567af5460b63aa3f654c1a653ac1a2cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d0f10d81a44adb3a0f44ef3742d65ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3513190ce3b551923788211c3bee05a7 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01T1-161 |
| filingDate | 2020-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30d172469ae9ae2b19467280cd779d74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6434b686301ab147f991b878bd4ea38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fffcd2547ca9023279dfc6f15e45d14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdf4e13c7935da7d7ed93f967b7aec50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46e33180093293b7d6a4ec15854825ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec7c6a00a4cd17fbfc674d8e81235aa4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c20f0c2429ea9b97066f7ac40dd3ca38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20cc785fb1ea197e41def3c25b574fae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_864d9e4dc84e7a8dc1aeb0348c87c6c0 |
| publicationDate | 2021-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2021076598-A |
| titleOfInvention | Analytical equipment and analysis program |
| abstract | PROBLEM TO BE SOLVED: To provide an analysis device capable of evaluating the comprehensive pharmacokinetics of 5-FU and the efficacy of 5-FU without imposing a burden on a patient. An analysis device 200 includes an extraction unit 205c, a calculation unit 205d, and an evaluation unit 205e. The extraction unit extracts the detected values in the tumor region, blood region, and muscle region from the nuclear medicine image of the subject to which the drug labeled with radioactivity is administered to the anticancer drug that exerts its effect by accumulating in the tumor. To do. The calculation unit is the first comparison value, which is the comparison result of the detection value in the blood region and the detection value in the tumor region, and the second comparison value, which is the comparison result of the detection value in the muscle region and the detection value in the tumor region. Is calculated. The evaluation unit evaluates the accumulation of the drug in the tumor based on the first comparison value and the second comparison value calculated by the calculation unit. [Selection diagram] Fig. 1 |
| priorityDate | 2019-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 513.